KORU Medical Systems, Inc.
KRMD
$4.32
$0.051.17%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.23% | 22.12% | 19.57% | 19.65% | 17.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.23% | 22.12% | 19.57% | 19.65% | 17.99% |
| Cost of Revenue | 26.06% | 23.77% | 17.44% | 9.87% | 4.28% |
| Gross Profit | 20.03% | 21.14% | 20.85% | 26.10% | 27.67% |
| SG&A Expenses | 8.08% | 11.28% | 9.77% | 9.54% | 6.22% |
| Depreciation & Amortization | -8.78% | -6.90% | -3.07% | -1.58% | 2.10% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.99% | 10.34% | 9.85% | 6.02% | 3.36% |
| Operating Income | 53.89% | 43.09% | 32.08% | 37.55% | 37.23% |
| Income Before Tax | 56.86% | 43.43% | 32.04% | 39.30% | 37.96% |
| Income Tax Expenses | 655.17% | -99.63% | -99.61% | -99.94% | -99.93% |
| Earnings from Continuing Operations | 56.52% | 68.99% | 61.60% | 60.07% | 55.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 56.52% | 68.99% | 61.60% | 60.07% | 55.85% |
| EBIT | 53.89% | 43.09% | 32.08% | 37.55% | 37.23% |
| EBITDA | 59.82% | 46.53% | 34.38% | 40.01% | 39.64% |
| EPS Basic | 56.86% | 69.16% | 61.75% | 60.22% | 55.98% |
| Normalized Basic EPS | 57.07% | 43.72% | 32.38% | 39.61% | 37.91% |
| EPS Diluted | 54.68% | 69.16% | 61.75% | 60.22% | 55.98% |
| Normalized Diluted EPS | 57.07% | 43.72% | 32.38% | 39.61% | 37.91% |
| Average Basic Shares Outstanding | 0.84% | 0.66% | 0.56% | 0.47% | 0.44% |
| Average Diluted Shares Outstanding | 0.84% | 0.66% | 0.56% | 0.47% | 0.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |